GSK

1,956.5

-1.29%↓

PETS

185.7

-1.59%↓

GSK

1,956.5

-1.29%↓

PETS

185.7

-1.59%↓

GSK

1,956.5

-1.29%↓

PETS

185.7

-1.59%↓

GSK

1,956.5

-1.29%↓

PETS

185.7

-1.59%↓

GSK

1,956.5

-1.29%↓

PETS

185.7

-1.59%↓

Search

Hikma Pharmaceuticals PLC

Abierto

SectorSanidad

1,474 -0.81

Resumen

Variación precio

24h

Actual

Mínimo

1469

Máximo

1491

Métricas clave

By Trading Economics

Ingresos

165M

Ventas

41M

1.7B

P/B

Media del Sector

10.771

49.052

BPA

1.07

Rentabilidad por dividendo

5.74

Margen de beneficios

9.698

Empleados

9,400

EBITDA

152M

411M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+23.99% upside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

5.74%

2.36%

Próximas Ganancias

6 ago 2026

Próxima Fecha de Ex Dividendo

13 ago 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-526M

3.1B

Apertura anterior

1474.81

Cierre anterior

1474

Noticias sobre sentimiento de mercado

By Acuity

43%

57%

118 / 342 Clasificación en Healthcare

Hikma Pharmaceuticals PLC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Acerca de Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
help-icon Live chat